Presented by Ms. Darlene Mueller Director, Laboratory Quality and Process Improvement Fraser Health, Providence Health Care, Provincial Health Services Authority, and Vancouver Coastal Health, Vancouver Objectives: Define and describe risk management (WHAT) Describe accreditation requirements for

Presented by Dr. Jason Acker Senior Scientist Canadian Blood Services, Edmonton Learning objectives Challenge you to think about what other factors besides storage which may be affecting the quality of “what’s in the bag” Provide evidence that blood product quality affects transfusion patient

Presented by Dr. Oksana Prokopchuk-Gauk Transfusion Medicine Physician Saskatchewan Health Authority, Saskatoon Learning objectives Review the principles of the National Plan for Shortages of Labile Blood Components Provide an overview of blood inventory determination within hospitals Discuss an

Presented by Dr. Katerina Pavenski Head, Division of Transfusion Medicine Medical Director, Therapeutic Apheresis and Patient Blood Management St. Michael's Hospital, Toronto Learning objectives Be able to recognize TMA that requires PLEX Be able to order appropriate investigations to aid in

Presented by Dr. Sandra Cohen Associate Professor, Université de Montréal Hematologist - Department Stem Cell Transplant/Cell Therapy Maisonneuve Rosemont Hospital, Montreal Learning objectives Identify the different hematopoietic stem cell sources Cord blood transplant: advantages and disadvantages

Presented by Dr. Christine Cserti Associate Medical Director - Blood Transfusion Laboratory University Health Network, Toronto Learning objectives Identify traditional to modern, and voluntary to involuntary, disqualifiers of transfusion. Describe the available and theoretical hacks for insufficient

Défi Chaîne de vie Organisée par Chaîne de vie Le Défi Chaîne de vie est un grand rassemblement où toutes les personnes de la chaîne du don se rassemblent pour appuyer Chaîne de vie, un programme éducatif unique visant à faire de nos jeunes de 15 à 17 ans des ambassadeurs de la discussion en famille

Presented by Dr. Yoelys Cruz-Leal Postdoctoral Fellow Canadian Blood Services, Toronto Learning objectives Describe the cause of hemolytic disease of the fetus and newborn (HDFN) and evaluate the effectiveness of current prophylaxis. Analyze the proposed mechanisms of action of Rh immune globulin

Presented by Dr. Sarah Jennings Presented by Dr. Sarah Jennings Associate Director Plasma Protein and Related Products Formulary Program Canadian Blood Services, Ottawa Learning objectives Review the hierarchy of evidence Discuss common types of bias in clinical trials Understand common methods of

Presented by Dr. Heather Hume Full Clinical Professor, Department of Pediatrics, University of Montreal Department of Hematology/Oncology, CHU Sainte-Justine, Montreal Learning objectives To briefly review the statistics regarding transfusion-transmitted (TT) HCV and HIV in Canada prior to the onset